Page last updated: 2024-10-21

tramiprosate and Diarrhea

tramiprosate has been researched along with Diarrhea in 1 studies

tramiprosate: GABA receptor agonist and a glycosaminoglycan mimetic; has nootropic acitivity; structure; a sulfonate analog of GABA
3-aminopropanesulfonic acid : An amino sulfonic acid that is the 3-amino derivative of propanesulfonic acid.

Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aisen, PS1
Saumier, D1
Briand, R1
Laurin, J1
Gervais, F1
Tremblay, P1
Garceau, D1

Trials

1 trial available for tramiprosate and Diarrhea

ArticleYear
A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Neurology, 2006, Nov-28, Volume: 67, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Diarrhea; Dose-Response Re

2006